Human anterior/middle Brain nerve precursor Cell Injection(Asia Stem Cell Regenerative Pharma)

人前/中脑神经前体细胞注射液（浙江泉生生物）

Report date: 2026/01/07 13:54:35

Base Information

Drug NameHuman anterior/middle Brain nerve precursor Cell Injection(Asia Stem Cell Regenerative Pharma)
Drug Alias Name人前/中脑神经前体细胞注射液ACT121ACT-121
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeHemiplegia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAsia Stem Cell Regenerative Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAsia Stem Cell Regenerative Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeHemiplegia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A